8-K
SI-BONE Reports Q3 2026 Financial Results and Reaffirms 2026 Revenue Guidance
8-K
SI-BONE Reports Voluntary Recall of Certain iFuse TORQ Implants and Lease Amendment for Corporate Headquarters
8-K
SI-BONE, Inc. Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance
8-K
SI-BONE, Inc. Announces Lease Extension and Annual Meeting Voting Results
8-K
SI-BONE Reports Q1 2026 Financial Results and Raises Full-Year 2026 Revenue Guidance
8-K
SI-BONE Reports Record 2025 Results with 20% Revenue Growth and Positive Adjusted EBITDA; Issues 2026 Guidance
